Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Glycoprotein antibody

The Rabbit Polyclonal anti- antibody has been validated for WB and IHC. It is suitable to detect in samples from Human and Mouse.
Catalog No. ABIN635807

Quick Overview for Glycoprotein antibody (ABIN635807)

Target

Glycoprotein

Reactivity

  • 4
  • 1
  • 1
Human, Mouse

Host

  • 4
  • 1
Rabbit

Clonality

  • 4
  • 1
Polyclonal

Conjugate

  • 5
Un-conjugated

Application

  • 4
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
Western Blotting (WB), Immunohistochemistry (IHC)
  • Purification

    Affinity purified

    Immunogen

    Glycoprotein antibody was raised using a synthetic peptide corresponding to a region with amino acids DENDWNEKLYPVWKRGDMRWKNSWKGGRVQAVLTSDSPALVGSNITFAVN
  • Application Notes

    WB: 1 µg/mL, IHC: 4-8 µg/mL
    Optimal conditions should be determined by the investigator.

    Comment

    Glycoprotein Blocking Peptide, (ABIN937299), is also available for use as a blocking control in assays to test for specificity of this Glycoprotein antibody

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    Lyophilized powder. Add distilled water for a 1 mg/mL concentration of GPNMB antibody in PBS

    Concentration

    Lot specific

    Buffer

    PBS

    Handling Advice

    Avoid repeated freeze/thaw cycles.

    Storage

    4 °C/-20 °C

    Storage Comment

    Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
  • Target

    Glycoprotein

    Target Type

    Viral Protein

    Background

    GPNMB is a type I transmembrane glycoprotein which shows homology to the pMEL17 precursor, a melanocyte-specific protein. GPNMB shows expression in the lowly metastatic human melanoma cell lines and xenografts but does not show expression in the highly metastatic cell lines. GPNMB may be involved in growth delay and reduction of metastatic potential.

    Molecular Weight

    60 kDa (MW of target protein)
You are here:
Chat with us!